Key regions: United States, South Korea, Japan, Canada, India
The Digestive & Intestinal Remedies (Pharmacies) market in Asia is experiencing significant growth and development.
Customer preferences: Customers in Asia are increasingly seeking digestive and intestinal remedies from pharmacies due to a variety of factors. One of the main reasons is the changing dietary habits and lifestyles in the region. As more people adopt Western diets and experience digestive issues, there is a growing demand for products that can alleviate these problems. Additionally, the increasing awareness about the importance of gut health and the role it plays in overall well-being has also contributed to the rise in demand for digestive and intestinal remedies.
Trends in the market: One of the key trends in the Digestive & Intestinal Remedies (Pharmacies) market in Asia is the growing popularity of natural and herbal remedies. Customers are becoming more conscious about the ingredients in the products they consume and are opting for natural alternatives. This trend is driven by the belief that natural remedies are safer and have fewer side effects compared to conventional medicines. As a result, pharmacies in Asia are witnessing an increase in the demand for herbal digestive and intestinal remedies. Another trend in the market is the rise in online sales of digestive and intestinal remedies. With the increasing penetration of smartphones and internet access in the region, customers are increasingly turning to online platforms to purchase healthcare products. This shift towards e-commerce has provided pharmacies with new opportunities to reach a wider customer base and expand their market presence.
Local special circumstances: Asia is a diverse region with different countries having unique healthcare systems and cultural preferences. This diversity influences the demand for digestive and intestinal remedies in each country. For example, in countries like China and India, traditional medicine systems such as Traditional Chinese Medicine (TCM) and Ayurveda have a strong presence. This has led to a preference for herbal remedies derived from these traditional systems. In addition, the aging population in countries like Japan and South Korea has also contributed to the growth of the Digestive & Intestinal Remedies (Pharmacies) market. As people age, they are more prone to digestive problems and require remedies to manage their symptoms. This demographic trend has created a steady demand for digestive and intestinal remedies in these countries.
Underlying macroeconomic factors: The growing middle class in Asia is a key driver of the Digestive & Intestinal Remedies (Pharmacies) market. As disposable incomes rise, more people have the financial ability to purchase healthcare products, including digestive and intestinal remedies. This has led to an increase in the overall market size and is expected to continue driving growth in the future. Furthermore, the increasing healthcare expenditure in the region is also contributing to the development of the market. Governments in many Asian countries are prioritizing healthcare and investing in improving healthcare infrastructure. This has resulted in better access to healthcare services, including pharmacies, and has further fueled the demand for digestive and intestinal remedies. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Asia is witnessing significant growth and development. Customer preferences for natural remedies and the rise of online sales are key trends in the market. Local special circumstances, such as traditional medicine systems and the aging population, also play a role in shaping the demand for digestive and intestinal remedies. Additionally, underlying macroeconomic factors such as the growing middle class and increasing healthcare expenditure are driving the growth of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
